Inventor · disambiguated record
Neil A. O'Brien
Also filed as: O'BRIEN NEIL · O'BRIEN NEIL A
6 granted patents·14 pending applications·3 citations·filing 2018–2025
69Inventor score
Top patents by PatentIndex Score
20 records- 0191US12065489B2Claudin-6 antibodies and drug conjugatesUNIV CALIFORNIA·Filed 2022·Granted Aug 20, 2024·2 cites·59 claims
- 0287US11834499B1Claudin18 antibodies and methods of treating cancerUNIV CALIFORNIA·Filed 2022·Granted Dec 5, 2023·1 cites·99 claims
- 0381US2025333501A1Claudin 4 and claudin 9 antibodies and methods of treating cancerUNIV CALIFORNIA·Filed 2025·Application pending·0 cites
- 0480US2025066469A1Claudin-6 antibodies and drug conjugatesUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 0579US2024400674A1Claudin 4 and claudin 9 antibodies and methods of treating cancerUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 0674US2024390374A1Mocetinostat in combination with chemotherapy to treat rhabdomyosarcomaUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 0772US2022372134A1Claudin6 antibodies and methods of treating cancerUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 0866US12403202B2Dosage of claudin-6 conjugates for cancer treatmentUNIV CALIFORNIA·Filed 2024·Granted Sep 2, 2025·0 cites·27 claims
- 0965US12345709B2CLAUDIN18 antibodies and methods of treating cancerUNIV CALIFORNIA·Filed 2020·Granted Jul 1, 2025·0 cites·15 claims
- 1063US2020291111A1Claudin6 antibodies and methods of treating cancerUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 1163US2022280510A1Mocetinostat in combination with chemotherapy to treat rhabdomyosarcomaUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1263US2022162299A1Claudin-6 antibodies and drug conjugatesUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 1357US2025042992A1Dlk1 antibodies and methods of treating cancerUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1457US2025051437A1Cdh17 antibodies and methods of treating cancerUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1554US2025136582A1Select kras g12c inhibitors and uses thereof1200 PHARMA LLC·Filed 2022·Application pending·0 cites
- 1649US12486280B2CDK inhibitors and uses thereofCALIFORNIA INST OF TECHN·Filed 2019·Granted Dec 2, 2025·0 cites·23 claims
- 1747US12428416B2ERK inhibitors and uses thereofCALIFORNIA INST OF TECHN·Filed 2019·Granted Sep 30, 2025·0 cites·20 claims
- 1847US2022177583A1Claudin-6 bispecific antibodiesUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 1946US2023116602A1Mcl1 inhibitors and uses thereofCALIFORNIA INST OF TECHN·Filed 2020·Application pending·0 cites
- 2044US2022227738A1Kras g12c inhibitors and uses thereofCALIFORNIA INST OF TECHN·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Neil A. O'Brien files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →